Pharma News, 2016

AstraZeneca has sold the European and Latin American rights to its new gout drug Zurampic to private German drugmaker Gruenenthal for up to $230 million, following a similar disposal of U.

Biogen and AbbVie have secured approval from the US Food and Drug Administration for Zinbryta (daclizumab) to treat adults with relapsing forms of multiple sclerosis (MS).

An HIV drug first approved less than three years ago is being rolled out in Botswana as a core medicine for newly diagnosed patients, following the largest ever tender secured by GlaxoSmithKline's...

Sanofi announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.

RIDGEFIELD, Conn.

Ireland-based Jazz Pharmaceuticals Plc will buy U.

KL001If you are a frequent traveller and get bogged down by jet lag with every flight, help is on the way.

ATLANTA— A protein designed by researchers at Georgia State University can effectively target a cell surface receptor linked to a number of diseases, showing potential as a therapeutic treatment for...

Teva, the world’s largest maker of copycat medicines, is racing to complete its $41bn acquisition of a rival generic drugmaker, but some shareholders and healthcare bankers argue the Israeli company...

Washington, May 27 (PTI) -- One of the most widely prescribed pain and anti-inflammation drug may also slow the growth rate of cancer, a new study has found.

The world's first life-saving gene therapy for children, developed by GlaxoSmithKline and Italian scientists, was approved for sale in Europe on Friday, in a step forward for the pioneering techno...

The Food and Drug Administration this week approved the first buprenorphine implant for the treatment of opioid dependence.